Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 1997; Volume 51,Issue 1

Accelerated Communications

  • You have access
    Ibogaine: A Potent Noncompetitive Blocker of Ganglionic/Neuronal Nicotinic Receptors
    Barbara Badio, William L. Padgett and John W. Daly
    Molecular Pharmacology January 1997, 51 (1) 1-5; DOI: https://doi.org/10.1124/mol.51.1.1
  • You have access
    D1-like Dopaminergic Activation of Phosphoinositide Hydrolysis Is Independent of D1A Dopamine Receptors: Evidence from D1A Knockout Mice
    Eitan Friedman, Li-Qing Jin, Guo-Ping Cai, Tom R. Hollon, John Drago, David R. Sibley and Hoau-Yan Wang
    Molecular Pharmacology January 1997, 51 (1) 6-11; DOI: https://doi.org/10.1124/mol.51.1.6

Articles

  • You have access
    Role of Determinants of Cadmium Sensitivity in the Tolerance ofSchizosaccharomyces pombe to Cisplatin
    Paola Perego, Jennifer Vande Weghe, David W. Ow and Stephen B. Howell
    Molecular Pharmacology January 1997, 51 (1) 12-18; DOI: https://doi.org/10.1124/mol.51.1.12
  • You have access
    Long Term Blockade of Serotonin Reuptake Affects Synaptotagmin Phosphorylation in the Hippocampus
    Maurizio Popoli, Alberto Venegoni, Claudia Vocaturo, Liliana Buffa, Jorge Perez, Enrico Smeraldi and Giorgio Racagni
    Molecular Pharmacology January 1997, 51 (1) 19-26; DOI: https://doi.org/10.1124/mol.51.1.19
  • You have access
    Regulation of Mouse Neuropeptide Y Y1 Receptor Gene Transcription: A Potential Role for Nuclear Factor-κB/Rel Proteins
    Rita Musso, Mariagrazia Grilli, Alessandra Oberto, Silvana Ricci Gamalero and Carola Eva
    Molecular Pharmacology January 1997, 51 (1) 27-35; DOI: https://doi.org/10.1124/mol.51.1.27
  • You have access
    Genetic Alteration of α2C-Adrenoceptor Expression in Mice: Influence on Locomotor, Hypothermic, and Neurochemical Effects of Dexmedetomidine, a Subtype-Nonselective α2-Adrenoceptor Agonist
    Jukka Sallinen, Richard E. Link, Antti Haapalinna, Timo Viitamaa, Maya Kulatunga, Birgitta Sjöholm, Ewen Macdonald, Markku Pelto-Huikko, Tiina Leino, Gregory S. Barsh, Brian K. Kobilka and Mika Scheinin
    Molecular Pharmacology January 1997, 51 (1) 36-46; DOI: https://doi.org/10.1124/mol.51.1.36
  • You have access
    Synthesis and Effect of Nonhydrolyzable Xanthosine Triphosphate Derivatives on Prenylation of Rab5D136N
    Ivan Yanachkov, Julie Y. Pan, Marianne Wessling-Resnick and George E. Wright
    Molecular Pharmacology January 1997, 51 (1) 47-51; DOI: https://doi.org/10.1124/mol.51.1.47
  • You have access
    Altered Sensitivity of Aspirin-Acetylated Prostaglandin G/H Synthase-2 to Inhibition by Nonsteroidal Anti-Inflammatory Drugs
    Joseph A. Mancini, Philip J. Vickers, Gary P. O’Neill, Catherine Boily, Jean-Pierre Falgueyret and Denis Riendeau
    Molecular Pharmacology January 1997, 51 (1) 52-60; DOI: https://doi.org/10.1124/mol.51.1.52
  • You have access
    Substitution of Charged Amino Acid Residues in Transmembrane Regions 6 and 7 Affect Ligand Binding and Signal Transduction of the Prostaglandin EP3 Receptor
    Laurent Audoly and Richard M. Breyer
    Molecular Pharmacology January 1997, 51 (1) 61-68; DOI: https://doi.org/10.1124/mol.51.1.61
  • You have access
    Discordant Hepatic Expression of the Cell Division Control Enzyme p34 cdc2 Kinase, Proliferating Cell Nuclear Antigen, p53 Tumor Suppressor Protein, and p21 Waf1 Cyclin-Dependent Kinase Inhibitory Protein after WY14,643 ([4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthio]Acetic Acid) Dosing to Rats
    Xinfang Ma, Dana A. Stoffregen, Geoffrey D. Wheelock, Joseph A. Rininger and John G. Babish
    Molecular Pharmacology January 1997, 51 (1) 69-78; DOI: https://doi.org/10.1124/mol.51.1.69
  • You have access
    The Majority of N-Methyl-d-Aspartate Receptor Complexes in Adult Rat Cerebral Cortex Contain at Least Three Different Subunits (NR1/NR2A/NR2B)
    Jianhong Luo, Yuehua Wang, Robert P. Yasuda, Anthone W. Dunah and Barry B. Wolfe
    Molecular Pharmacology January 1997, 51 (1) 79-86; DOI: https://doi.org/10.1124/mol.51.1.79
  • You have access
    μ-Opioid Receptor-Stimulated Guanosine-5′-O-(γ-thio)-triphosphate Binding in Rat Thalamus and Cultured Cell Lines: Signal Transduction Mechanisms Underlying Agonist Efficacy
    Dana E. Selley, Laura J. Sim, Ruoyo Xiao, Qixu Liu and Steven R. Childers
    Molecular Pharmacology January 1997, 51 (1) 87-96; DOI: https://doi.org/10.1124/mol.51.1.87
  • You have access
    Down-Regulation of P2U-Purinergic Nucleotide Receptor Messenger RNA Expression During In Vitro Differentiation of Human Myeloid Leukocytes by Phorbol Esters or Inflammatory Activators
    Kathleen A. Martin, Sylvia B. Kertesy and George R. Dubyak
    Molecular Pharmacology January 1997, 51 (1) 97-108; DOI: https://doi.org/10.1124/mol.51.1.97
  • You have access
    Characterization of Recombinant Human P2X4 Receptor Reveals Pharmacological Differences to the Rat Homologue
    Miguel Garcia-Guzman, Florentina Soto, Juan Manuel Gomez-Hernandez, Per-Eric Lund and Walter Stühmer
    Molecular Pharmacology January 1997, 51 (1) 109-118; DOI: https://doi.org/10.1124/mol.51.1.109
  • You have access
    Cloning and Expression of Rat Metabotropic Glutamate Receptor 8 Reveals a Distinct Pharmacological Profile
    Julie A. Saugstad, J. Mark Kinzie, Michi M. Shinohara, Thomas P. Segerson and Gary L. Westbrook
    Molecular Pharmacology January 1997, 51 (1) 119-125; DOI: https://doi.org/10.1124/mol.51.1.119
  • You have access
    Inhibition of the Cardiac Sarcolemma Na+/Ca2+ Exchanger by Conformationally Constrained Small Cyclic Peptides
    Daniel Khananshvili, Brenda Mester, Miriam Saltoun, Xiaolan Wang, Gilat Shaulov and David Baazov
    Molecular Pharmacology January 1997, 51 (1) 126-131; DOI: https://doi.org/10.1124/mol.51.1.126
  • You have access
    Lack of Enantiospecificity of Human 2′-Deoxycytidine Kinase: Relevance for the Activation of β-l-Deoxycytidine Analogs as Antineoplastic and Antiviral Agents
    Annalisa Verri, Federico Focher, Giuseppina Priori, Gilles Gosselin, Jean-Louis Imbach, Massimo Capobianco, Anna Garbesi and Silvio Spadari
    Molecular Pharmacology January 1997, 51 (1) 132-138; DOI: https://doi.org/10.1124/mol.51.1.132
  • You have access
    Aminoacyl and Peptidyl Analogs of Chloramphenicol as Slow-Binding Inhibitors of Ribosomal Peptidyltransferase: A New Approach for Evaluating Their Potency
    Maria Michelinaki, Petros Mamos, Charalambos Coutsogeorgopoulos and Dimitrios L. Kalpaxis
    Molecular Pharmacology January 1997, 51 (1) 139-146; DOI: https://doi.org/10.1124/mol.51.1.139
  • You have access
    Evidence for a Role of a Perferryl-Oxygen Complex, FeO3+, in the N-Oxygenation of Amines by Cytochrome P450 Enzymes
    F. Peter Guengerich, Alfin D. N. Vaz, Gregory N. Raner, Steven J. Pernecky and Minor J. Coon
    Molecular Pharmacology January 1997, 51 (1) 147-151; DOI: https://doi.org/10.1124/mol.51.1.147
  • You have access
    Agonist Activation of δ-Opioid Receptor but not μ-Opioid Receptor Potentiates Fetal Calf Serum or Tyrosine Kinase Receptor-Mediated Cell Proliferation in a CellLine-Specific Manner
    P. Y. Law, T. M. McGinn, K. M. Campbell, L. E. Erickson and H.H. Loh
    Molecular Pharmacology January 1997, 51 (1) 152-160; DOI: https://doi.org/10.1124/mol.51.1.152
  • You have access
    Mechanism of Phosphorylation-Recognition by Visual Arrestin and the Transition of Arrestin into a High Affinity Binding State
    Vsevolod V. Gurevich and Jeffrey L. Benovic
    Molecular Pharmacology January 1997, 51 (1) 161-169; DOI: https://doi.org/10.1124/mol.51.1.161
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 51 (1)
Molecular Pharmacology
Vol. 51, Issue 1
1 Jan 1997
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Accelerated Communications
  • Articles
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity
  • P2X7 Positive Modulator Structure-Activity Relationship
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics